GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 74 filers reported holding GALENA BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,012,000 | -21.2% | 2,882,645 | +4.7% | 0.00% | – |
| Q2 2016 | $1,284,000 | -60.7% | 2,753,970 | +14.7% | 0.00% | – |
| Q1 2016 | $3,265,000 | -5.9% | 2,401,646 | +1.7% | 0.00% | – |
| Q4 2015 | $3,470,000 | +1.6% | 2,361,122 | +9.2% | 0.00% | – |
| Q3 2015 | $3,416,000 | -1.4% | 2,161,879 | +6.1% | 0.00% | – |
| Q2 2015 | $3,466,000 | +40.6% | 2,037,772 | +14.9% | 0.00% | – |
| Q1 2015 | $2,466,000 | -7.8% | 1,774,048 | +0.1% | 0.00% | – |
| Q4 2014 | $2,676,000 | -24.7% | 1,772,817 | +2.7% | 0.00% | – |
| Q3 2014 | $3,555,000 | -29.3% | 1,726,565 | +5.1% | 0.00% | -100.0% |
| Q2 2014 | $5,027,000 | -72.1% | 1,643,083 | -77.2% | 0.00% | -50.0% |
| Q1 2014 | $18,011,000 | -27.8% | 7,203,845 | +42.1% | 0.00% | 0.0% |
| Q4 2013 | $24,951,000 | +1135.8% | 5,070,770 | +469.6% | 0.00% | – |
| Q3 2013 | $2,019,000 | +8.3% | 890,259 | +6.1% | 0.00% | – |
| Q2 2013 | $1,864,000 | – | 839,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |